When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - ViiV files U.S. application for two-drug combo for HIV
Pfizer Inc.
ViiV Healthcare has submitted a New Drug Application (NDA) to the FDA seeking approval its once-per-month injectable two-drug regimen, cabotegravir and Janssen's rilpivirine, for the treatment of adults with HIV-1 infection whose viral load is suppressed and who are not resistant to either drug.
More news on: Johnson & Johnson, GlaxoSmithKline plc, Pfizer Inc., Healthcare stocks news,